A Research Study Looking at How a Single Dose of the Medicine Cagrilintide Works in Participants With Reduced Liver Function and in Healthy Participants With Normal Liver Function and How Cagrilintide is Absorbed and Used by the Body

Clinical trial NCT05564104 · COMPLETED

Trial details

NCT number: NCT05564104
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Impairment Healthy Volunteers

Start date: 2023-04-05
Primary completion: 2024-09-06
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.